Replimune CEO Sushil Patel Sells 37,324 Shares

What Happened
Sushil Patel, CEO of Replimune Group, sold 37,324 shares of Replimune common stock on May 18, 2026 for a total reported value of $189,606. The reported (weighted average) price was about $5.08 per share; individual trades ranged from $5.01 to $5.08. This was a sale and was executed to satisfy tax withholding on a partial vesting of restricted stock units (RSUs), not an opportunistic discretionary sale.

Key Details

• Transaction date: May 18, 2026 (filed on May 20, 2026) — filing appears timely (two days after the trade).
• Shares sold: 37,324; weighted-average price reported ≈ $5.08; trade prices ranged $5.01–$5.08.
• Total proceeds reported: $189,606.
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnotes: Sale was a mandatory "sell to cover" to satisfy tax withholding on RSU vesting (irrevocable per award agreement) and therefore was not a discretionary sale by the CEO. The filer can provide per-trade pricing on request.

Context
This was a routine tax-withholding sale tied to RSU vesting (common when shares vest). Such sell-to-cover transactions are generally administrative and less informative about the insider’s view of the company than voluntary open-market purchases.